Literature DB >> 32783504

Effectiveness of non-pharmacological interventions for treating post-stroke depressive symptoms: Systematic review and meta-analysis of randomized controlled trials.

Yejin Lee1, Brian Chen1, Mandy W M Fong2, Jin-Moo Lee2, Ginger E Nicol3, Eric J Lenze3, Lisa T Connor4, Carolyn Baum4, Alex W K Wong5.   

Abstract

OBJECTIVE: To compare the effectiveness of non-pharmacological interventions on depressive symptoms in people after stroke. DATA SOURCES: A literature search was performed through databases from January 2000 to August 2018: MEDLINE; CINAHL Plus; Scopus; Academic Search Complete; Cochrane Central Register of Controlled Trials; Scopus; and Library, Information Science and Technology Abstracts. Search terms included depression, stroke, non-pharmacologic, and intervention. STUDY SELECTION: We included randomized controlled trials comparing non-pharmacological interventions to controls for depressive symptoms in people after stroke. Of 1703 identified articles, 22 trials were included in narrative synthesis, of which 13 were eligible for meta-analysis. DATA EXTRACTION: Two reviewers extracted characteristics of participants, interventions, and results from all included trials. DATA SYNTHESIS: Thirteen interventions were categorized into four types: complementary and alternative therapy (five trials, n=228), exercise (four trials, n=263), psychosocial therapy (two trials, n=216), and multifactorial therapy (two trials, n=358). Overall beneficial effects of non-pharmacological interventions on depressive symptoms were found both post-intervention (effect size [ES] = -0.24, 95% confidence Interval [CI]: -0.37 to -0.11, p < 0.05) and at follow-up (ES = -0.22, CI: -0.36 to -0.07, p< 0.05). We found individual beneficial effects for complementary and alternative therapy (ES = -0.29, CI: -0.55 to -0.02, p < 0.05) and psychosocial therapy (ES = - 0.33, CI: -0.60 to -0.06, p < 0.05) post-intervention.
CONCLUSIONS: Complementary and alternative therapy and psychosocial therapy appear to be promising strategies for improving post-stroke depression. Future studies target  a personalized approach for people with specific conditions such as cognitive impairment.

Entities:  

Keywords:  Non-pharmacological interventions; behavior therapy; complementary therapies; depression; meta-analysis; neuropsychiatry; psychosocial therapy; stroke; systematic review

Mesh:

Year:  2020        PMID: 32783504      PMCID: PMC7878573          DOI: 10.1080/10749357.2020.1803583

Source DB:  PubMed          Journal:  Top Stroke Rehabil        ISSN: 1074-9357            Impact factor:   2.119


  44 in total

1.  Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs.

Authors:  Scott B Morris; Richard P DeShon
Journal:  Psychol Methods       Date:  2002-03

2.  National Institutes of Health Toolbox Emotion Battery: Application of Summary Scores to Adults With Spinal Cord Injury, Traumatic Brain Injury, and Stroke.

Authors:  Ida Babakhanyan; Noelle E Carlozzi; Benjamin S McKenna; Kaitlin B Casaletto; Allen W Heinemann; Robert K Heaton
Journal:  Arch Phys Med Rehabil       Date:  2019-05-31       Impact factor: 3.966

Review 3.  Therapy for prevention of post-stroke depression.

Authors:  Rajamannar Ramasubbu
Journal:  Expert Opin Pharmacother       Date:  2011-06-29       Impact factor: 3.889

Review 4.  A systematic review of therapeutic interventions for poststroke depression and the role of nurses.

Authors:  Janneke M de Man-van Ginkel; Floor Gooskens; Marieke J Schuurmans; Eline Lindeman; Thóra B Hafsteinsdottir
Journal:  J Clin Nurs       Date:  2010-12       Impact factor: 3.036

Review 5.  Psychological treatment of depression in inpatients: a systematic review and meta-analysis.

Authors:  Pim Cuijpers; Frans Clignet; Berno van Meijel; Annemieke van Straten; Juan Li; Gerhard Andersson
Journal:  Clin Psychol Rev       Date:  2011-01-16

6.  Comparing patient characteristics, type of intervention, control, and outcome (PICO) queries with unguided searching: a randomized controlled crossover trial.

Authors:  Arjen Hoogendam; Pieter F de Vries Robbé; A John P M Overbeke
Journal:  J Med Libr Assoc       Date:  2012-04

7.  Management of depression in elderly stroke patients.

Authors:  Johan Lökk; Ahmad Delbari
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

Review 8.  Antidepressant therapy in post-stroke depression.

Authors:  Sergio E Starkstein; Romina Mizrahi; Brian D Power
Journal:  Expert Opin Pharmacother       Date:  2008-06       Impact factor: 3.889

Review 9.  The effectiveness of nonpharmacological interventions in older adults with depressive disorders: a systematic review.

Authors:  João Apóstolo; Paulo Queirós; Manuel Rodrigues; Inês Castro; Daniela Cardoso
Journal:  JBI Database System Rev Implement Rep       Date:  2015-07-17

10.  Effectiveness of music intervention in ameliorating cancer patients' anxiety, depression, pain, and fatigue: a meta-analysis.

Authors:  Hsiu F Tsai; Ying R Chen; Min H Chung; Yuan M Liao; Mei J Chi; Chia C Chang; Kuei R Chou
Journal:  Cancer Nurs       Date:  2014 Nov-Dec       Impact factor: 2.592

View more
  3 in total

Review 1.  Preventive Approaches for Post-Stroke Depression: Where Do We Stand? A Systematic Review.

Authors:  Warunya Woranush; Mats Leif Moskopp; Annahita Sedghi; Isabella Stuckart; Thomas Noll; Kristian Barlinn; Timo Siepmann
Journal:  Neuropsychiatr Dis Treat       Date:  2021-11-19       Impact factor: 2.570

2.  The efficacy of therapies for post-stroke depression in aging: An umbrella review.

Authors:  Jinlu Xie; Xiwen Geng; Fangcheng Fan; Xuyan Fu; Shuaibing He; Tao Li
Journal:  Front Aging Neurosci       Date:  2022-08-23       Impact factor: 5.702

3.  Effectiveness of non-pharmacological interventions for treating post-stroke depression: Study protocol of an umbrella review of systematic reviews and meta-analyses.

Authors:  Chengcheng Zhang; Lianyi He; Zhendong Li; Hangjian Qiu; Xiaoqian Wang; Yuejuan Zhang
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.